{
    "Trade/Device Name(s)": [
        "UniCAP Specific IgE"
    ],
    "Submitter Information": "Pharmacia Diagnostics AB",
    "510(k) Number": "K051218",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHB"
    ],
    "Summary Letter Date": "June 9, 2005",
    "Summary Letter Received Date": "May 12, 2005",
    "Submission Date": "May 11, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) Immunological Test System"
    ],
    "Analyte Class(es)": [
        "allergy",
        "immunology"
    ],
    "Analyte(s)": [
        "Allergen specific IgE"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ImmunoCAP 100/UniCAP 100",
        "ImmunoCAP/UniCAP 250",
        "ImmunoCAP/UniCAP 1000"
    ],
    "Method(s)/Technology(ies)": [
        "Automated in vitro quantitative assay",
        "Enzyme immunoassay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Quantitative immunoassay",
        "Fluorescence measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent",
        "System",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for UniCAP Specific IgE in vitro quantitative assay for allergen specific IgE measurement with calibration curve modification",
    "Indications for Use Summary": "Intended for in vitro quantitative measurement of allergen specific IgE in human serum or plasma as an aid in clinical diagnosis of IgE mediated allergic disorders, to be used in clinical and physician office laboratories with ImmunoCAP/UniCAP instruments",
    "fda_folder": "Immunology"
}